https://www.selleckchem.com/pr....oducts/Vorinostat-sa
7%), P = 0.102). Moreover, we found that the remission rate was similar between fibrous and soft tumors (P = 0.873) and also of surgical complications (P = 0.859), despite of the higher prevalence of Knosp 2 (P = 0.035) and very large PA (P = 0.025) in fibrous tumors than in soft tumors. Although presurgical treatment with high doses of SRL was associated with a 2.2-fold greater chance of surgical remission, this benefit was not related with changes in tumor consistency induced by the presurgical treatment. Although presurgi